Discovery of novel antibiotics

Product or Service High throughput screening and lead discovery

A large network of 17 experienced screening centres, including two institutes with focus on infectious diseases.

Technology:
  • Antimicrobial compound/strategy
  • Infection prevention
  • Antimicrobial stewardship
  • Microbial diagnostics
  • Removal antibiotics/bacteria

Microorganisms:
  • Bacteria
  • Viruses
  • Fungi
  • Parasites
  • Yeasts

Application:
  • Human
  • Veterinary
  • AgriFood
  • Environmental
  • Other

Development stage:
  • Research
  • Development
  • Validation
  • Market entry
  • Marketed product

Organization:
  • Academia
  • Company
  • Institute
  • NGO
  • Government

Partnering:
  • License
  • Co-develop
  • Joint Venture
  • Outsource
  • Sell

Funding organisation:
  • OTHER / NA
  • CARB-X
  • FIND
  • GARDP
  • REPAIR

Infectious disease area:
  • UTI
  • STI
  • BSI
  • RTI
  • GII
  • SSTI
  • CNSI
  • IAI
  • SSI

Geographic origin:
  • Eurasia
  • North America
  • South America
  • Africa
  • Oceania


Embargo period of up to three years before screening data become open access. EU-OPENSCREEN works with full cost model and claims no IPR.

European research infrastructure consortium (ERIC) for chemical biology

Access to commercial and proprietary compound collections, medicinal chemistry expertise at 6 sites. Co-development of novel screening technologies.


What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed